TrialCancer chemotherapy and pharmacology2014

Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001).

T Dragovich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.